相关实验视频
Updated: Jul 23, 2025

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.4K
通过CRISPR/Cas在癌症中准miRNA:优势和挑战
Bashdar Mahmud Hussen1,2, Mohammed Fatih Rasul3, Snur Rasool Abdullah4
1Department of Biomedical Sciences, Cihan University-Erbil, Erbil, Kurdistan Region, 44001, Iraq.
Military Medical Research
|July 17, 2023
概括
聚类调节间隔短平行体重复 (CRISPR) 基因编辑通过向microRNAs (miRNAs) 提供了新的癌症治疗途径. 本研究探讨了基于miRNA的安全有效的癌症治疗的先进CRISPR/Cas策略,解决当前的挑战.
科学领域:
- 生物医学科学 生物医学科学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 在过去的十年里,CRISPR/CRISPR相关蛋白 (Cas) 系统彻底改变了生物医学研究.
- 克里斯普尔/卡斯技术为了解癌症提供了新的方法,包括非编码基因组,瘤异质性和精密医学.
研究的目的:
- 为了突出尖端的CRISPR/Cas基因编辑疗法,针对癌症治疗的microRNAs (miRNAs).
- 讨论与CRISPR/Cas介导的miRNA基因编辑在癌症治疗中的挑战.
- 提出克服这些挑战的先进策略,并开发安全有效的癌症基因编辑疗法.
主要方法:
- 对当前适用于癌症治疗的CRISPR/Cas基因编辑技术的审查.
- 分析使用CRISPR/Cas系统向微RNA (miRNA) 的策略.
- 评估与CRISPR/Cas基因编辑相关的安全考虑和潜在异常.
主要成果:
- 克里斯普尔/卡斯技术使得癌症治疗中突变和微RNA (miRNA) 的精确向成为可能.
- 有效和安全的癌症基因编辑疗法开发需要精心设计,以避免伤害正常细胞.
- 正在开发先进的策略,以应对CRISPR/Cas介导的miRNA基因编辑方面的挑战.
结论:
- 基于CRISPR/Cas的基因编辑对开发针对miRNA的新型癌症疗法具有重大前景.
- 克服与安全性和疗效相关的挑战对于这些疗法的临床转化至关重要.
- 对先进策略的进一步研究将为更安全,更有效的miRNA向癌症治疗铺平道路.
相关概念视频
CRISPR
52.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.4K
CRISPR/Cas9 Genome Editing
72
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
72
CRISPR and crRNAs
17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K

